Trial Profile
Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 12 Jun 2019 Planned End Date changed from 11 Jun 2019 to 1 Nov 2019.
- 12 Jun 2019 Planned primary completion date changed from 11 Jun 2019 to 1 Oct 2019.
- 17 Jun 2018 Planned End Date changed from 1 Jun 2019 to 11 Jun 2019.